Ubs Asset Management Americas Inc Inhibrx, Inc. Transaction History
Ubs Asset Management Americas Inc
- $277 Billion
- Q1 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Inhibrx, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 29,580 shares of INBX stock, worth $419,148. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,580
Previous 32,217
8.19%
Holding current value
$419,148
Previous $1.22 Million
15.52%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding INBX
# of Institutions
132Shares Held
35.5MCall Options Held
64.8KPut Options Held
91.3K-
Viking Global Investors LP7.15MShares$101 Million0.95% of portfolio
-
Perceptive Advisors LLC New York, NY4.26MShares$60.3 Million3.12% of portfolio
-
Black Rock Inc. New York, NY2.75MShares$39 Million0.0% of portfolio
-
State Street Corp Boston, MA2.42MShares$34.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.86MShares$26.4 Million0.0% of portfolio
About Inhibrx, Inc.
- Ticker INBX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,057,700
- Market Cap $553M
- Description
- Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...